verified_user
Standardful
Export Controls

China Proposes New AI, Biopharma and Solar Technology Export Controls

China opened consultation on 40 AI, biopharma and solar technologies while making temporary pre-export registration immediately applicable.

calendar_today•schedule 5 min read•personStandardful Team
China Proposes New AI, Biopharma and Solar Technology Export Controls

China's Ministry of Commerce (MOFCOM) and Ministry of Science and Technology opened consultation on proposed additions to the Catalogue of Technologies Prohibited or Restricted from Export on 16 October 2026.

The proposal covers 40 technologies:

FieldProposed technologies
Artificial intelligence23
Biopharma5
Solar manufacturing12

According to MOFCOM's official Q&A, 14 would be prohibited and 26 restricted. The draft catalogue changes are not final. Comments are open through 15 November 2026.

One obligation is already live: until the revised catalogue is formally issued and implemented, exporters must complete pre-export registration for technology within the announcement's attached scope.

What requires immediate attention

The temporary registration requirement applies before an in-scope export involving:

  • transfer of technology ownership, including intellectual-property transfers;
  • licensing Chinese technology for use overseas;
  • a change that makes an overseas party the owner or actual controller of the Chinese technology; or
  • another transaction that MOFCOM specifically requires to be registered.

Transactions that started before 16 October but are not yet complete are also covered when they fall within the announced scope.

Registration is made through MOFCOM's technology-trade system and includes the exporter and recipient, destination, technology and intended use, and expected value. This is a temporary registration measure, not proof that the draft catalogue has already become final.

Important scope distinctions

The proposal does not make every overseas AI, medicine or solar sale a controlled technology export.

  • AI: MOFCOM says the central test is whether restricted technology is transferred from China. Its Q&A distinguishes overseas technology deployment from API access, web or app interaction, SaaS and lightweight local deployment. Technology already in the public domain through open source or published academic work is proposed to remain outside the new controls.
  • Biopharma: the draft targets defined pathogen, cell and gene therapy, and small-nucleic-acid technologies. Some licensing, contract research, manufacturing and humanitarian or joint-research scenarios may qualify for exclusions or simplified licensing described in the official materials.
  • Solar: the proposal reaches defined polysilicon, wafer and cell manufacturing technologies. Key or core equipment carrying listed technology can also be relevant; an ordinary product sale should not be assumed to transfer the underlying production know-how.

The exact technical thresholds are in the official attachment. Companies should classify against that text rather than against broad sector labels.

Five actions for affected companies

  1. Freeze the transaction list. Identify incomplete and planned cross-border licensing, IP, deployment, engineering-service, equipment and ownership-change transactions.
  2. Classify the technology. Map technical parameters and know-how to the attachment, recording why each item is inside or outside scope.
  3. Separate product from technology transfer. Review source code, models, process recipes, operating parameters, training, commissioning and technical assistance—not only shipped goods.
  4. Register before export when required. Assign an owner for MOFCOM registration and retain the filing record with the transaction approval.
  5. Submit comments and monitor the final text. Reassess contracts and licensing paths when the consultation closes and the final catalogue is published.

Organizations already using ISO/IEC 42001 or ISO/IEC 27001 can reuse technology inventories, access controls and approval records, but neither certification determines Chinese export-control scope.

FAQ

Is the proposed catalogue revision already final?

No. The AI, biopharma and solar additions are a consultation draft open for comments through 15 November 2026. The temporary pre-export registration requirement is separate and took effect on 16 October 2026.

Which transactions require temporary registration?

The announcement covers transfers of technology ownership, licensing Chinese technology for overseas use, a change of the Chinese technology owner or actual controller to an overseas party, and other cases notified by MOFCOM. In-scope exports already started but not completed are included.

Are AI APIs and SaaS automatically controlled?

No. MOFCOM says the key question is whether a listed restricted technology is transferred from China. The official Q&A says API calls, app or web interaction, SaaS and lightweight local deployment are not treated as large-model technology exports merely because those services are supplied overseas.

Research and review

This update distinguishes the consultation draft from the temporary registration measure that is already effective. It was reviewed against MOFCOM's announcement and official Q&A on 16 October 2026. The attachment and final catalogue should be rechecked before any transaction decision.

Official sources

  1. MOFCOM and Ministry of Science and Technology Announcement No. 48 of 2026 — consultation, temporary registration and official attachments
  2. MOFCOM spokesperson Q&A — scope, proposed categories and treatment of common transaction models

Related Topics

China export controlstechnology exportartificial intelligencebiopharmasolar technologyMOFCOM